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THE clinical problems ofbreast carcinoma have been underintensive discussion
for decades. A great deal of detailed information has been accumulated, but
still widely different views are entertained as to diagnosis, treatment and thera-
peutic results. Our present knowledge was amply illustrated during the panel
discussion on treatment and results in cancer ofthe breast at the thirtieth annual
meeting ofthe American Radium Society, Chicago (1948), and at the twenty-fifth
meeting oftheNorthern Surgical Association, Copenhagen (1951), to which readers
may be referred.
A few points seem to be universally acknowledged, as regards treatment.
Firstly, a careful and extensive surgical intervention will, in a number ofcases,
be life saving, or life prolonging. The condition is that the tumour has not spread
beyond the field of operation. On the other hand, if the surgeon operates in a
field where cancerous cells are present and the operation is incomplete, the surgeon
may by his intervention precipitate an outburst of metastases and shorten the
life ofthe patient. It may further be agreed that the development ofthe special
surgical technique since the days of Halstead and Meyer is comparatively small,
and that the advances, as manifested by a higher curerate, are modest and mostly
caused by improvements of surgery in general, for instance the introduction of
penicillin and a better postoperative regime, thereby reducing the immediate
operative dangers. It was this state of affairs that caused McWhirter (1949)
to state: " When radical mastectomy is the only method of treatment available
and when all cases coming to a large general hospital are taken into account, the
five-year survival rate is unlikely to exceed 25 per cent ".
Secondly, it seems generally accepted that radiological treatment in a certain,
restricted number ofcases and under certain conditions, is ableto effect a complete
destruction of the tumour cells and thereby be life-saving. It further seems
generally accepted that radiological treatment in other cases may, for a shorter
or longer period, retard the development and the spread ofthe tumour cells, and
that radiological treatment thereby may be life prolonging. Kreyberg (1938)
microscopically examined breast carcinomas and axillary metastases which had
been submitted to pre-operative irradiation. The material came from three
different hospitals, using different radiological techniques and different doses.
The conclusions were that-: a pre-operative treatment, with the doses used, may
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in a series of cases damage the tumour cells to a degree, histologically visible,
and in rare cases lead to complete disappearance of the tumour cells. This effect
is dependent upon the dose, the effect being more pronounced after stronger
doses. Also the axillary metastases are damaged, but in a considerably lower
degree than the primary tumour. But, even after the strongest doses (with
tele-radium), a great number of tumours show such small changes that we must
conclude that the cells are growing during and in spite of the treatment. These
observations have been generally confirmed. Kaae (1952) stated that only
15 per cent of all breast carcinomas are really radiosensitive. Baclesse (1949)
had greater effects, but he used very heavy doses. An observation period of 5
years only is, however, too brief, since one of the radiological effects is fibrosis
and scarring, after which cancer cells, retarded in growth, may regain their vitality
and proliferative possibilities at a later date. Haagensen (1949) stated "Our
reliance upon irradiation for the cure of the disease (breast carcinoma) has fal-
tered until we have come to the point where we reserve irradiation for cases in
which palliation is all that can be hoped for."
An attempt has been made to combine surgical and radiological treatment,
in the hope of obtaining better results. Two main lines have been followed in
Scandinavia, the Swedish line (Forssell), characterized by a pre-operative X-ray
treatment with moderate doses, and the Danish (Nielsen, Kaae), and especially
the Norwegian (Engelstad) line, characterized by a post-operative treatment with
heavy doses, preferably by tele-radium.
The lively discussion of the theoretical foundations and the speculations
as to the mode of action on one hand, and the insignificant differences between
the two methods as regards curative results on the other, bear sufficient witness
that the improvements are not very great, or even unequivocal.
Thirdly, other therapeutic means, especially hormone treatment, may have
a marked palliative effect and to a limited degree be life prolonging, but sterili-
sation ofthe tumour cells cannot be obtained.
Fourthly, all students with a wider experience will have observed in very rare
cases extraordinary retrogressions of advanced breast tumours with widely spread
metastases, and more often delays in the development, which it is difficult to
explain as results of therapeutic interventions, and where one is inclined to accept
intrinsic biological processes antagonistic to the life and further development of
the tumour cells.
If we accept these basic facts, our next problem is to try to assess more pre-
cisely the limits ofour therapeutic means, and here we meet considerable obstacles.
If two gardeners arrive at the market, one with five and the other with ten
boxes of perfect apples, no one will venture an opinion as to who is the most
successful gardener without asking how many apple trees each of them is culti-
vating. This is, however, just what is done in many cases, where statistics are
prepared presenting the therapeutic results from different hospitals and institu-
tions without regard to the total number of patients received in the institutions
and suffering from the disease under discussion.
Winter (1902) fifty years ago proposed a programme as to how our thera-
peutic results ought to be presented. These principles have been accepted by
the gynecologists co-operating inthe League of Nations Health Organization.
Haagensen (1949) urged a similar attitude in the statistical presentation of
"
cures
" and survival of sufferers from breast carcinoma, claiming that the
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absolute or over-all cure rate only is significant, a standpoint strongly supported
by McWhirter (1949). The absolute or over-all curerateis thenumber ofpatients
alive andsymptom-free out ofthetotalnumber ofpatients received inthehospital
and suffering from the disease under investigation. All dead are counted as
victims of said disease, regardless of the real cause of death. Even if this strict
attitude is adopted, we meet, however, with factors which influence the statistics.
Firstly, the general cancer consciousness ofthe society, which to a certain degree
will influence the relative number of early and late cases. Secondly, social and
racial factors, which may influence the soil of the cancer cells, and thirdly, the
relative number of cases with moderate and with high malignancy, as shown by
Bloom (1950). Kreyberg (1952) in a survey oflung cancer in Norway attempted
to showthat the difference inthe sex distribution ofthis form ofcancerin Norway,
as compared to England and Wales, may be explained by the difference in the
relative number ofthe different histological types. A similar situation may hold
good for breast carcinoma as well. It is probable, therefore, that besides a plea
fortheuseofabsolute curerates andtumourstages alreadyin use, also a correction
for tumour types and grades should be attempted.
Nielsen (1951) gave as reasonable the following figures as the average chances
for a breast carcinoma patient in Scandinavia:
5-year survival rate, symptom free (operable cases), 35-50 per cent.
5-year survival rate, symptom free (absolute), 20-30 per cent.
These figures are valid for a population with a generally fair cancer conscious-
ness and with a rather high standard ofthe doctors and the hospitals. Individual
surgeons and special clinics may present better results, but such material is more
or less selected.
The cause of the depressingly low cure rate in breast carcinoma is two-fold:
(1) the tumour cells have spread beyond surgical control before the operation is
performed and even before the diagnosis is made, and/or (2) the tumour cells are
not sufficiently radiosensitive.
This state of affairs has naturally led to a quest for other means of improving
the therapeutic results, and as one ofthose, the importance of " early diagnosis "
has been universally stressed and accepted. It may be useful therefore to
examine the meaning ofthe designation " early diagnosis ". In the present paper
it is intended to examine different definitions of the term " early diagnosis "
commonly used in order to ascertain our position today as regards the criteria
for the immediate recognition of a breast carcinoma in a stage where a complete
cure is possible, if a proper treatment actually at our disposal is used. Especially
will be examined the foundation of a propoganda promising great hopes of cure if
the patient arrives for treatment on the basis of an " early diagnosis ".
When a breast carcinoma develops morbid changes have usually been present
in the tissue for a shorter or a longer period. Even if the essential change is
considered to be a somatic mutation in a single cell, this mutation has its local
cause. Further, the tissue is not clinically cancerous before the proliferation
has reached a certain extent. From a therapeutic standpoint to-day the breast
carcinoma is in its early phase as long as the tumour is localized to a degree that
makes a complete cure possible by such a relatively simple local operation as
mastectomy. This is the background for the designation " Stage I ", and in the
absolute sense mastectomy should by definition in such cases result in 100 per
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cent cures. If a lower percentage is obtained it is because the tumour is question
had already spread further and was no longer in Stage I.
One definition of
"early diagnosis
" (pl), covering a common usage, may
be a diagnosis made when the tumour is still in Stage I.
If we inquire into the means of arriving at an early diagnosis, as stated in
Pl, we find that the simplest staging is the immediate clinical, whereby the pal-
pating fingers try to ascertain the presence or absence of regional lymph nodes.
Nohrman (1949) stated that in his series 28 per cent ofthe cases clinically diagnosed
as StageI, by subsequent histological examination were shown to be in Stage II
or higher. Haagensen (1949) quoted a much higher figure, 45 per cent, as
covering his experience. This immediate clinical staging is therefore considered
useless for scientific and practical work.
More exact is the histological staging, where the grouping of tumours depends
upon the finding, or not, of tumour cells in the local lymph nodes. This staging
is also subject to serious errors. Firstly, tumour cells may actually be present
in the lymph nodes and the pathologist fails to find them. Secondly, tumour
cells may have entered other lymphatic channels, by-passing the axillary lymph
nodes. Handley (1952) found metastases in the intrathoracic lymph nodes,
without involvement of the regional nodes in 3 per cent of his cases, and Mar-
gottini (1952) found the same situation in 5 per cent of his cases. Thirdly, a
certain number of tumours develop haematogenous metastases without involving
any lymph nodes at all. The discrepancy between the number of tumours histo-
logically classified as Stage I and the number of cures effected in this group, after
a proper local operation, shows the degree of failure in the process of staging.
This failure is approximately 20-30 per cent. In spite of this serious inaccuracy
the histological staging is the method used for grouping of tumours for comparing
different therapeutic interventions.
The most accurate staging is the retrospective clinical, taking into considera-
tion the final development of the cancerous process in each individual. But
even this staging is not perfect. It has been mentioned that patients supposed
to be Stage I eventually are shown to be in StageII or further. On the other
hand, patients believed to be StageI, though actually in Stage II, may never be
recognized as such if radiological treatment cures the patient.
This brief survey shows that the decisive determination of the stage of a
certain tumour is neither a direct nor an immediate process. A proper and com-
paratively certain estimate of the correct stage of a tumour takes from 15 to 20
years. The criteria are mainly obtainable as a result of a retrospective clinical
survey.
The definition of
"early diagnosis", as given inPi is useful in theoretical
discussions of biological aspects of the tumour problem and for assessing the
cure rates in connection with different therapeutic means and circumstances.
If, on the other hand, patients are urged to seek
"early diagnosis " in cases of
breast cancer, the definition, as given inPl, is useless, because the definition does
not give criteria immediately available to recognize a breast cancer still in Stage I.
Another attempt at a useful definition of " early diagnosis
" may be tentatively
a diagnosis made in immediate sequence to the first symptom from the tumour
regardless of the type of symptom (p2). This definition is very often silently
admitted as valid, and commonly used.
A great number of students have examined the main symptoms of breast
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cancer, and have correlated the time lag between the discovery ofthe first symp-
tom and the commencement of treatment on one side and the curative results
on the other. It has, generally, tacitly been accepted that the longer the delay,
the poorer the results. This sounds very reasonable and the statement evidently
holds good in most individual cases, because most tumours begin as a local pro-
liferation and gradually expand and eventually spread.
Korteweg, however, already in 1880 pointed out the remarkable observation
that the groups of breast cancer patients with the longest periods of symptoms
showed the best curative results, and in a later paper (1889) advanced the explana-
tion that a natural selection of carcinomas with a relatively low malignancy took
place during the delay. Bloom (1950) has ably reviewed this problem and has
analysed his own material from this angle. His results are shown in Table I.
TABLE I.-Duration of Symptom8 and Prognosis (Bloom, 1950).
Duration
of symptoms.
6 weeks or less .
3 months or less
3-6 months
6-12 months
12 months or more
Cases.
101
184
125
118
105
5-year survivals.
r I
Number. Per cent.
50 50
94 51
59 47
56 - 47
55 52
Bloom concluded that the survival rate is uniform, no matter how long the
history. The explanation is that the groups have not a uniform composition.
Bloom showed that in the first groups is a greater number of highly malignant
tumours than in the latter, and stated that: " We are thus faced with the fact
that by the time a highly malignant growth (Grade III) is discovered by the
patient it is, in all probability, too late to eradicate, direct extension and meta-
stases having already taken place."
Kreyberg and Christiansen (1953) have recently studied the same problem,
considering the grades of the tumours, and have mainly supported Bloom's con-
clusion.
This conclusion holds good for groups of cases. In single individual cases
it will not hold good. Even the most malignant tumour will have a Stage I,
however brief the period may be, and even the lowest grade malignant tumour
may one day spread and pass into Stage II, or further.
If we turn from the comparison of different groups of patients with varying
time lag, and consider the absolute curative results in the groups with the shortest
delay in treatment only, we may collect the figures shown inTable II from recent
literature.
TABLE II.-The Cure Rate in Breast Carcinomas with a Short Delay in Treatment.
Duration of Observation period and
Author. symptoms. Per cent. type of" cure."
Luff (1932) . . . 4 weeks maximum . 31 . 4 years survival "in good health."
Eggers, de Cholnoky,
Jessup (1941)
Nohrman (1949)
. 4 ,
8 ,,
2 ,,
4 ,
Kreyberg, Christiansen
(1953) . . . 4 ,,
,, . 76
50
, 9 . 55
9,, . 52
c - :
5 years " arrest."
5 ,.
5 years " survival."
5 , ..
62 . 10 years " survival symptom
free " (very small tumours
only).
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This table shows that even in these groups, where the time lag between diag-
nosis and commencement of treatment is reduced to the practical minimum,
only half of the average patients can count upon a 5 years' survival symptom
free. It seems, therefore, that the definition P2 is of rather limited usefulness
because a great number of the tumours are not any longer curable and the de-
finition has not contained the criteria necessary to obtain this goal. A limited
usefulness ofP2 is demonstrated by the fact that some patients, an unknown num-
ber, have benefited from the shorter time lag-a question which will be discussed
later.
Ifwe analyse the usual symptoms, some ofthem (a feeling ofheaviness, pains,
stinging sensation and similar) are rather vague and strictly subjective and little
fitted for attempts at earlier detection. But among the symptoms analysed, a
lump inthe breast is the first in at least three-fourths ofall cases, andthissymptom
is more material, more objective and more fitted for diagnostic research. Here
a regular and systematic palpation may facilitate the discovery of comparatively
small nodules, but there evidently is a certain lower size limit.
Another attempt at a useful definition may accordingly be: a diagnosis of
a very small tumour (p3), in the hope that all such tumours actually are curable.
Kaae (1948) voiced the traditional opinion when he stated that: " It is
generally recognized that the size of the tumour is a very important factor in
the prognosis, and that the latter is much more favourable for the small tumours
than for the large."
If we, however, examine the pertinent literature, we shall discover that the
students ofthis problem are not at all unanimous. Bloom (1950), and Kreyberg
and Christiansen (1953) have recently considered this question and from the
last mentioned paper the following experience may be quoted. The material
consisted of small carcinomas, the size varying from that of a hazel nut to that
of a pea or a bean. The number of such small carcinomas was less than 6 per
cent of the total number of malignant breast tumours examined. The fate of
the patients was followed and the long range survey, ten to twenty year's obser-
vation, showed that nearly two-thirds of the patients had metastases when arriv-
ing for treatment. More than half of the patients died, or would eventually die
from their tumours. Even the very smallest carcinomas, those the size of a pea
or a bean, had a fatal outcome in four out often cases.
These facts show that our attempt to define " early diagnosis" as a diagnosis
of a very small tumour (P3), actually a tumour as small as practically diagnosable,
also fails miserably.
Taking into consideration the three commonly used or accepted definitions of
" early diagnosis ", Pi fails, because the criteria are not immediately available,
and P2 and p3 fail, because the criteria do not enable a patient to recognize a
tumour still in a curable stage. Nor is any other definition known, which makes
such a recognition possible to-day.
What P2 and P3 give are indications for obtaining the earliest possible diag-
nosis with our present diagnostic means. An examination of the actual degree
of earliness shows that only half of the tumours occurring in a population can,
under the best possible conditions, be diagnosed early enough to be cured with
our present therapeutic means. The reason is that nearly two-thirds of the
tumours have metastasized before the tumour is diagnosable, and only a part
of those are curable by surgical and/or radiological intervention.
162EARLY DIAGNOSIS OF BREAST CANCER
The situation is shown in a simplified form in Fig. 1. The Grade I tumours
are very slowly growing and late metastasizing. Early or late diagnosis is not
of very great importance. The Grade III tumours are very quickly growing
and very early metastasizing. Most of these tumours are beyond therapeutic
control before the primary tumour is diagnosed at all. The Grade II tumours
are in an intermediate position, and these are the tumours where the question
of earliness in diagnosis is of paramount importance. The number of such tum-
ours is not exactly known, but in large series of carcinomas where a well-known
history of development is available, data for a reasonable estimate should be at
hand.
Under these circumstances it seems strange that statements may be pro-
nounced, claiming that " in early cases of breast cancer " more than 90 per cent
Increasing
PREMALIGNANT PERIOD MANIFEST MALlGNANCY AND METASTASES
Fio. 1.-Diagrammatic representation ofthe downward path ofpatients with the three grades
of carcinoma of the breast, in relation to time and the increasing prominence of their
symptoms.
are cured. The word "earlye" is here evidently used in the same meaning as in
our definitions, discussed above, where earliness refers to a diagnosis and a treat-
ment when the tumour is still in a curable stage. Earliness and curability are
in this connection synonymous terms. The statement that " early cases " have
a high curability is therefore a tautology, saying that curable cases have a high
curability. The high percentage of cures is the result of a very strict selection
of cases. First all cases proved to belong to Stage II, or further, are excluded.
This would leave a curability of approximately 75 per cent for the remaining.
Next, larger tumours, and finally especially malignant-looking tumours, are ex-
cluded. The high percentage of cures is actually an expression of the analyst's
ability in retrospective selection ofcases. A further improvement in the statistics
may be obtained by a still greater efficiency in the process of selection, not neces-
sarily being an expression ofincreased chances for the patient at large to survive.
It is not correct and not fair to publish such statistics in a manner that makes
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the public believe that ifthe women examine themselves regularly and carefully,
and pay a visit to a competent doctor at the first suspicion ofa symptom from the
breast, their chances of a complete cure is in the vicinity of 90 per cent. The
truth is that the chances are somewhere in the vicinity of 50 per cent. Kaae
(1948) arrived at the same standpoint, and wrote: " It is indicated by these
investigations that a 5-year symptom-free survival rate of about 40 per cent is
obtainable in Denmark to-day, and that these results may be improved from 40
to 50 per cent, ifall patients see a doctor as soon as they notice the first symptom,
and if the doctor makes the correct diagnosis and institutes adequate treatment
without delay ".
The present study seems to show that a diagnosis as early as possible is of
great importance to a certain, yet unknown, number of individual breast car-
cinoma patients. As we do not beforehand know who will benefit and who will
not, a general plea for " early diagnosis " is fully substantiated, as every indi-
vidual salvaged is important. We must, however, always have in mind that
the benefit is statistically moderate, and we ought to be modest in our claims as
to the possibility of materially altering the situation for the breast carcinoma
patients by this approach to the problem.
It has finally to be added that the present conclusion is based upon the use
of the word " early " as an expression of curability seen on the background of
our present diagnostic and therapeutic means. As soon as one or both of these
factors are altered, a new appreciation ofthe situation will have to be made.
SUMMARY AND CONCLUSION.
After a survey of the facts available, according to which the prospective
chances of a breast carcinoma patient are shown to be very far from satisfactory,
and according to which likewise the advances in treatment and cures have been
shown to be very modest, a semantic analysis has been carried out, regarding
the foundation of the claims that early diagnosis is of great importance for
obtaining better results.
The analysis has shown that the use of the term " early " refers to a state
where a breast carcinoma is curable with our present therapeutic means. The
term is not used in the sense of a more or less absolute time unit. Earliness is,
actually, here synonymous with curability to-day, and this again, in most cases,
means a carcinoma in Stage I.
If we examine the means to diagnose a carcinoma still in Stage I, we will
discover that such a diagnosis can with a reasonable certainty be made only
after a retrospective clinical survey, lasting some 15 to 20 years.
The analysis further shows that we have no criteria enabling an immediate
"eary diagnosis ", in the sense required. What we have at our disposal are the
criteria for making a diagnosis as early as possible with our present diagnostic
means. The efficacy ofthese criteria leads to an estimated optimal absolute cure
rate in the vicinity of 50 per cent.
The failure is caused by the fact that an important number of patients have
already developed metastases, beyond therapeutic control, at the moment of the
earliest possible diagnosis.
A plea for " early diagnosis " should nevertheless be maintained, because
earliness is of importance in a certain restricted number of individual cases.
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